School of Medicine
Showing 21-30 of 50 Results
-
Clifford Sheckter, MD, MS, FACS
Assistant Professor of Surgery (Plastic and Reconstructive Surgery)
BioDr. Cliff Sheckter is a California native, growing up in the rural Eastern Sierra. He graduated from UCLA with a BS in Anthropology and earned summa cum laude and Phi Beta Kappa honors. He attended USC (Keck) for medical school on an academic scholarship and graduated valedictorian with Alpha Omega Alpha honors. He fell in love with burn care while at USC/LA General Medical Center and completed surgical training at Stanford. While in residency, he pursued a fellowship/postdoc in Health Systems Design at Stanford’s Clinical Excellence Research Center (CERC). He earned an MS in Health Policy from Stanford, focusing on health economics. He received additional training in Surgical Critical Care and Burn Surgery at the University of Washington.
Dr. Sheckter is a health services and health policy researcher. His work focuses on burn prevention and health economics in surgical care. He has authored over 150 articles and numerous book chapters. His research has been published in JAMA, JAMA Network Open, JAMA Surgery, Annals of Surgery, Journal of Plastic & Reconstructive Surgery, Burns, and Journal of Burn Care & Research. His work has been featured in USA Today and the New York Times. He was the recipient of a career development award from the NIH and has funding from the Plastic Surgery Foundation. Dr. Sheckter was awarded the American Burn Association (ABA) Traveling Fellow for 2023 and has won top abstract at the ABA Annual Meeting multiple times. He is an active member of the ABA and Chairs the Burn Prevention Committee.
Dr. Sheckter is one of a few surgeons double-board certified in Surgical Critical Care and Plastic & Reconstructive Surgery. He practices critical care medicine as an intensivist in the Stanford Surgical ICU. He is the Director of the Regional Burn Center at Santa Clara Valley Medical Center which is the only burn/trauma center for the San Francisco Bay Area. He performs scar reconstruction using surgical and laser techniques. -
Andrew A. Shelton, MD, FACS, FACRS
Clinical Professor, Surgery - General Surgery
Current Research and Scholarly InterestsMultimodality treatment of rectal cancer
Sphincter preserving procedures for rectal cancer
Laparoscopic colon and rectal surgery
Surgical education -
Dennis Shem
Clinical Assistant Professor, Surgery - Plastic & Reconstructive Surgery
BioDr. Shem is a Clinical Assistant Professor in the Section of Dental Medicine and Surgery at Stanford University. He trained in Dental Oncology at Memorial Sloan Kettering Cancer Center, focusing on oral complications of cancer therapy and non-surgical management of patients with osteoradionecrosis (ORN) and medication-related osteonecrosis of the jaw (MRONJ). He also trained in Oral and Maxillofacial Pathology at Columbia University and has expertise in diagnosing and managing oral mucosal diseases.
As a dental oncologist and oral pathologist, he evaluates patients before and after organ and stem-cell transplant, radiation therapy, chemotherapy, and bisphosphonate therapy. He has particular interest in oral manifestations of systemic disease, oral complications of systemic therapy, and oral dysplasia. -
Prof Christopher Shen MD
Adjunct Professor, Medicine - Surgery
Academic Staff - Hourly - CSL, SurgeryBioDr. Christopher Shen is an Adjunct Professor in the Stanford School of Medicine, the Director of Global Programs at the Stanford Mussallem Center for Biodesign, and a member of the Stanford Biodesign Leadership Council. Dr. Shen is also the Founding Executive Director of the Singapore Stanford Biodesign Program.
Dr. Shen has been a longstanding member of the Stanford community since 1991, completing degrees in Biological Sciences, Biomechanical Engineering, Business, and Medicine. He has been teaching graduate and undergraduate students since 2001.
A strong proponent of interdisciplinary and experiential education, Dr. Shen has dedicated his career to teaching medical, engineering, and business students at Stanford and abroad in foundational concepts underpinning design-thinking, clinical immersion, ideation, rapid prototyping, innovation, and entrepreneurship. In addition, Dr. Shen is responsible for establishing and/or managing collaborations between Stanford and Biodesign-like programs on every continent except Antarctica! He continues to annually mentor diverse groups of students to develop and implement innovative medical solutions to serve patients around the world.
Dr. Shen is the founding and current U.S. Executive Director of Singapore Stanford Biodesign since its inception in 2010. As the first Biodesign program in East Asia, its mission is to train the next generation of medical technology innovators throughout the Pacific Rim, focusing on the unique medical needs in the region. Supported by Singapore's national level research institute, the Agency for Science, Technology, and Research (ASTAR), and the National Research Foundation (NRF), the program has uniquely built bridges across Asia, spanning Singapore, China, Indonesia, Taiwan, Korea, Australia, and Malaysia. In total, the program has trained 60 Fellows and hundreds of students throughout the region.
Dr. Shen is also a Partner at Novo Holdings, the asset manager of the Novo Foundation, one of the largest philanthropic organizations in the world. With headquarters in Denmark, Novo Holdings is committed to investing in innovative companies that improve the health of people and planet. Dr. Shen started his career in medical innovation as a Senior Design Engineer at Guidant Neurovascular, where he was the principal inventor of one of the original stentriever devices for ischemic stroke. He has been issued twelve patents in the fields of interventional neuroradiology and interventional cardiology.
Dr. Shen was a Stanford Asia/Pacific Scholar and a Paul & Daisy Soros Fellow. -
Palca Shibale
Postdoctoral Scholar, Plastic and Reconstructive Surgery
BioShibale, Palca is a post-doctoral fellow in the Hagey Laboratory under mentorship of Dr. Derrick Wan and Michael Longaker. She earned her BS in Molecular and Cellular Biology at the University of Washington (UW), her MS in Medical Physiology and Biophysics at Case Western University and her MD from UW. She has previously conducted translational research on drug efficacy and clinical research in trauma and vascular surgery. Her current works focus on understanding the mechanisms of tissue regeneration and fibrosis with nano materials and as well, the roles of fibroblast subpopulations in the foreign body response model
